1-8 of 8
George Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts

Clinical Trials & Observations
Amer M. Zeidan, Uwe Platzbecker, Guillermo Garcia-Manero, Mikkael A. Sekeres, Pierre Fenaux, Amy E. DeZern, Peter L. Greenberg, Michael R. Savona, Joseph G. Jurcic, Amit K. Verma, Ghulam J. Mufti, Rena Buckstein, Valeria Santini, Jeevan K. Shetty, Rodrigo Ito, Jennie Zhang, George Zhang, Xianwei Ha, Jay T. Backstrom, Rami S. Komrokji
Journal: Blood
Blood (2022) 140 (20): 2170–2174.
https://doi.org/10.1182/blood.2022016171
Published: 2022
Includes: Supplemental data
Journal Articles

Effect of Luspatercept on Biomarkers of Erythropoiesis in Patients (Pts) with Lower-Risk Myelodysplastic Syndromes (LR-MDS) in the Medalist Trial

Uwe Platzbecker, Yiming Zhu, Xianwei Ha, Alberto Risueño, Esther Chan, George Zhang, Diana R. Dunshee, Melih Acar, Jeevan K. Shetty, Rodrigo Ito, Kyle MacBeth, Valeria Santini, Maciej W. Garbowski, Pierre Fenaux, MD PhD, Martin Schwickart
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-136705
Published: 2020
Journal Articles

Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the Medalist Study

Esther Natalie Oliva, MD, Uwe Platzbecker, Guillermo Garcia-Manero, MD, Ghulam J. Mufti, Professor, Valeria Santini, Mikkael A. Sekeres, Rami S. Komrokji, MD, Jeevan K. Shetty, Derek Tang, Shien Guo, Weiqin Liao, George Zhang, Xianwei Ha, Rodrigo Ito, Jennifer Lord-Bessen, Jay T. Backstrom, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-136276
Published: 2020
Journal Articles

Sustained Reductions in Red Blood Cell (RBC) Transfusion Burden and Events in β-Thalassemia with Luspatercept: Longitudinal Results of the Believe Trial

Ali T. Taher, Vip Viprakasit, Olivier Hermine, John B. Porter, MA, MD, FRCP, FRCPath, Antonio Piga, MD, Kevin H.M. Kuo, MDMSc,FRCPC, Thomas D. Coates, MD, Ersi Voskaridou, Abderrahim Khelif, Antonis Kattamis, Jeevan K. Shetty, George Zhang, Yu (Olivia) Tian, Dimana Miteva, Tatiana Zinger, Derek Tang, Jay T. Backstrom, Maria Domenica Cappellini
Journal: Blood
Blood (2020) 136 (Supplement 1): 45–46.
https://doi.org/10.1182/blood-2020-140310
Published: 2020
Journal Articles

Longitudinal Effect of Luspatercept Treatment on Iron Overload and Iron Chelation Therapy (ICT) in Adult Patients (Pts) with β-Thalassemia in the Believe Trial

Olivier Hermine, Maria Domenica Cappellini, Ali T. Taher, Thomas D. Coates, MD, Vip Viprakasit, Ersi Voskaridou, Ashutosh Lal, MD, Hong Keng Liew, Silverio Perrotta, Abderrahim Khelif, Antonis Kattamis, Jeevan K. Shetty, George Zhang, Yu (Olivia) Tian, Dimana Miteva, Tatiana Zinger, Derek Tang, Jay T. Backstrom, John B. Porter, MA, MD, FRCP, FRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 47–48.
https://doi.org/10.1182/blood-2020-136517
Published: 2020
Journal Articles

Efficacy and Safety of Luspatercept Treatment in Patients with Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T): A Retrospective Analysis from the Medalist Study

Rami S. Komrokji, MD, Uwe Platzbecker, Pierre Fenaux, MD PhD, Guillermo Garcia-Manero, MD, Ghulam J. Mufti, Professor, Valeria Santini, Maria Diez-Campelo, PhDMD, Carlo Finelli, Joseph G. Jurcic, MD, Peter L. Greenberg, Mikkael A. Sekeres, Amer M. Zeidan, MBBS, MHS, Amy E. DeZern, MD, Michael R. Savona, MD, Jeevan K. Shetty, Rodrigo Ito, George Zhang, Xianwei Ha, Daniel Sinsimer, Jay T. Backstrom, Amit Verma, MBBS
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–15.
https://doi.org/10.1182/blood-2020-137232
Published: 2020
Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): LBA-6.
https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6
Published: 2017
Journal Articles

Edoxaban For Long-Term Treatment Of Venous Thromboembolism In Cancer Patients

Gary E Raskob, PhD, Harry Buller, MD, PhD, Pantep Angchaisuksiri, MD, Doyeun Oh, MD, PhD, Zoltan Boda, MD, PhD, DSc, Roger M. Lyons, MD, Jeffrey I. Weitz, MD, George Zhang, PhD, Hans J Lanz, MD, Michele Mercuri, MD, PhD, FAHA
Journal: Blood
Blood (2013) 122 (21): 211.
https://doi.org/10.1182/blood.V122.21.211.211
Published: 2013